MRK vs ZTS
By Alex · Tickerpine
Merck & Co., Inc. vs Zoetis Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | ZTS |
|---|---|---|
| Price | $148.78 | $71.05 |
| Market cap | $367.07B | $29.36B |
| P/E ratio | 119.0 | 11.6 |
| ROE | 6.96% | 64.91% |
| Profit margin | 4.77% | 27.68% |
| Revenue growth | 5.10% | -0.20% |
| Dividend yield | 2.29% | 2.98% |
| Beta | 0.23 | 0.73 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs ZTS in plain English
- MRK is the bigger company — about 12.5× the market cap of ZTS.
- ZTS is cheaper on earnings (P/E 11.6 vs 119.0).
- ZTS earns a higher return on equity (65% vs 7%).
- MRK is growing revenue faster (5% vs -0%).
- ZTS has the higher dividend yield (2.98% vs 2.29%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
ZTS return calculator
See what $1,000 in Zoetis Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.